Loading...
Paclitaxel
India Pharmaceutical Trade Intelligence
Who Supplies Paclitaxel to India from CHINA
India's paclitaxel imports from CHINA total $252.9K across 6 shipments from 4 foreign suppliers. QILU PHARMACEUTICAL HAINAN CO LIMITED leads with $241.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CLIANTHA RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for paclitaxel — a diversified sourcing base with multiple active suppliers from CHINA.
Top foreign suppliers (CHINA) — Ranked by import value
QILU PHARMACEUTICAL HAINAN CO LIMITED is the leading Paclitaxel supplier from CHINA to India, with import value of $241.4K across 2 shipments. The top 5 suppliers — QILU PHARMACEUTICAL HAINAN CO LIMITED, Anbison Lab. Co., Ltd, XXENZXXN KXXAI XXALTXXAREXXO LXX, Anbison Lab. Co. LIMITED — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (CHINA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | QILU PHARMACEUTICAL HAINAN CO LIMITED | $241.4K | 2 | 95.4% |
| 2 | Anbison Lab. Co., Ltd | $7.8K | 2 | 3.1% |
| 3 | XXENZXXN KXXAI XXALTXXAREXXO LXX | $3.2K | 1 | 1.3% |
| 4 | Anbison Lab. Co. LIMITED | $474 | 1 | 0.2% |
Showing top 4 of 4 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CHINA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CLIANTHA RESEARCH LIMITED | $241.4K | 2 | 95.4% |
| 2 | CBCC GLOBAL RESEARCH LLP | $8.3K | 3 | 3.3% |
| 3 | INTAS PHARMACEUTICALS LIMITED | $3.2K | 1 | 1.3% |
Import Statistics
- Import Value
- $252.9K
- Shipments
- 6
- Foreign Suppliers
- 4
- Indian Buyers
- 3
- Avg. Shipment
- $42.1K
Other Paclitaxel Import Origins
Related Analysis
Frequently Asked Questions — Paclitaxel Imports from CHINA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Paclitaxel suppliers from CHINA to India?
The top Paclitaxel suppliers from CHINA to India include QILU PHARMACEUTICAL HAINAN CO LIMITED, Anbison Lab. Co., Ltd, XXENZXXN KXXAI XXALTXXAREXXO LXX. The leading supplier is QILU PHARMACEUTICAL HAINAN CO LIMITED with import value of $241.4K USD across 2 shipments. India imported Paclitaxel worth $252.9K USD from CHINA in total across 6 shipments.
QHow much Paclitaxel does India import from CHINA?
India imported Paclitaxel worth $252.9K USD from CHINA across 6 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Paclitaxel from CHINA?
The main Indian buyers of Paclitaxel sourced from CHINA include CLIANTHA RESEARCH LIMITED, CBCC GLOBAL RESEARCH LLP, INTAS PHARMACEUTICALS LIMITED. The largest buyer is CLIANTHA RESEARCH LIMITED with $241.4K in imports across 2 shipments.
QWhat is the total value of Paclitaxel imports from CHINA to India?
The total value of Paclitaxel imports from CHINA to India is $252.9K USD, across 6 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CHINA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Paclitaxel.
- 2.Supplier/Buyer Matching: 4 foreign suppliers from CHINA and 3 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $252.9K aggregated from 6 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6 Verified Shipments
4 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists